Show simple item record

dc.contributor.authorMasterson, Claire
dc.contributor.authorO’Toole, Daniel
dc.date.accessioned2018-09-20T16:16:15Z
dc.date.available2018-09-20T16:16:15Z
dc.date.issued2014-01-01
dc.identifier.citationMasterson, Claire; O’Toole, Daniel (2014). The mesenchymal stromal cell magic bullet finds yet another target. Stem Cell Research & Therapy 5 ,
dc.identifier.issn1757-6512
dc.identifier.urihttp://hdl.handle.net/10379/12677
dc.description.abstractRojas and colleagues have presented an exciting paper demonstrating yet another relevant preclinical setting in which the mesenchymal stromal cell has a potential therapeutic application. What is particularly interesting about this study is that it addresses a disease, blood-borne systemic sepsis, which has multiple complex host responses and involves a variety of disparate organs and immune cell types. Here, the authors focus on how this injury relates more specifically to the lung, with quite dramatic improvements in several assessed injury parameters. Where does this latest demonstration of mesenchymal stromal cell efficacy leave us with regard to getting these cell therapies to the acute respiratory distress syndrome patient?
dc.publisherSpringer Nature
dc.relation.ispartofStem Cell Research & Therapy
dc.subjectstem-cells
dc.titleThe mesenchymal stromal cell magic bullet finds yet another target
dc.typeArticle
dc.identifier.doi10.1186/scrt471
dc.local.publishedsourcehttp://doi.org/10.1186/scrt471
nui.item.downloads0


Files in this item

This item appears in the following Collection(s)

Show simple item record